Open access
2,474
Views
2
CrossRef citations to date
0
Altmetric
Research Paper
Preventive pharmacological treatment in subjects at risk for fatal familial insomnia: science and public engagement
Gianluigi Forlonia Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, ItalyCorrespondence[email protected]
View further author information
, View further author information
Ignazio Roiterb Ulss 2 Marca Trevigiana Ca’ Foncello Hospital, Treviso, ItalyView further author information
, Vladimiro Artusob Ulss 2 Marca Trevigiana Ca’ Foncello Hospital, Treviso, ItalyView further author information
, Manuel Marconc AFIFF, Treviso, ItalyView further author information
, Walter Colessoc AFIFF, Treviso, ItalyView further author information
, Elviana Lubanc AFIFF, Treviso, ItalyView further author information
, Ugo Luccaa Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, ItalyView further author information
, Mauro Tettamantia Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, ItalyView further author information
, Elisabetta Pupilloa Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, ItalyView further author information
, Veronica Redaellid Fondazione IRCCS Istituto Neurologico ”Carlo Besta”, Milano, ItalyView further author information
, Francesco Mariuzzoc AFIFF, Treviso, ItalyView further author information
, Giulia Boscolo Buleghinc AFIFF, Treviso, ItalyView further author information
, Alice Mariuzzoc AFIFF, Treviso, ItalyView further author information
, Fabrizio Tagliavinid Fondazione IRCCS Istituto Neurologico ”Carlo Besta”, Milano, ItalyView further author information
, Roberto Chiesaa Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, ItalyView further author information
& Anna Ambrosinie Fondazione Telethon ETS, Milano, ItalyView further author information
show all
Pages 66-77
|
Received 22 Feb 2022, Accepted 24 May 2022, Published online: 23 Jun 2022
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.